The TMF Lead II is responsible for oversight, management, and delivery of the eTMF in accordance with Good Clinical Practice (GCP), E6 ICH Guidelines and other regulatory guidance documents, relevant regulations (e.g., 21 CFR Parts 312 and 314, EMA Clinical Trials Directives), and Precision Standard Operating Procedures (SOPs) as appropriate. The TMF Lead II supports smaller and/or less complex studies.